Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period
Sakamoto, M.; Mikasa, K.; Majima, T.; Konishi, M.; Maeda, K.; Yoshimoto, E.; Murakawa, K.; Takahashi, K.; Kita, E.; Narita, N.
Japanese Journal of Antibiotics 53 Suppl A: 56-59
2000
ISSN/ISBN: 0368-2781 PMID: 10756453 Document Number: 519092
Document emailed within 1 workday
Related Documents
Fujita, A.; Igami, Y.; Takabatake, H.; Tagaki, S.; Yamamoto, R.; Sekine, K. 1999: Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(6): 805-811Tomeczko, J.; Napora, P.; Dlubek, D.; Pacuszko, T.; Bochenska, J.; Teucher, T.; Schmitz, H.; Lange, A. 1997: Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer Arzneimittel-Forschung 47(12): 1411-1416
Tamura, A.; Mikami, A.; Sagara, Y.; Hebisawa, A. 2000: Concurrent chemoradiotherapy using a single agent for unresectable stage IIi non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(11): 1755-1758
Muraki, M.; Toda, Y.; Haraguchi, R.; Sugihara, R.; Kubo, H.; Nakajima, S. 1991: Study of prognostic factors of survival in patients with unresectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(4): 585-592
Fram, R.; Skarin, A.; Balikian, J.; Amato, D.; Leslie, N.; Malcolm, A.; Frei, E. 1985: Combination chemotherapy followed by radiation therapy in patients with regional stage IIi unresectable non-small cell lung cancer Cancer Treatment Reports 69(6): 587-590
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Fujisawa, N.; Yoneda, M.; Abe, Y.; Inamori, M.; Kawamura, H.; Kirikoshi, H.; Shimamura, T.; Kubota, K.; Sakaguchi, T.; Saito, S.; Nakajima, A. 2006: Clinical features of long time survivors with unresectable pancreatic cancer treated by gemcitabine alone Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(2): 207-212
Miyatake, K.; Gemba, K.; Ueoka, H.; Nishii, K.; Kiura, K.; Tabata, M.; Shibayama, T.; Takigawa, N.; Kawaraya, M.; Tanimoto, M. 2003: Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer Anticancer Research 23(3c): 2829-2836
Rizou, T.; Perlikos, F.; Lagiou, M.; Karaglani, M.; Nikolopoulos, S.; Toumpoulis, I.; Kroupis, C. 2018: Development of novel real-time RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens Journal of BUON: Official Journal of the Balkan Union of Oncology 23(6): 1699-1710
Wolf, M.; Hans, K.; Becker, H.; Hässler, R.; von Bültzingslöwen, F.; Goerg, R.; Klaasen, H.A.; Dannhäuser, J.; Holle, R.; Pfab, R. 1994: Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 42-47
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Nakano, K.; Yamamoto, M.; Iwamoto, H.; Hiramoto, T. 2003: Daily low-dose cisplatin plus concurrent high-dose thoracic radiotherapy in elderly patients with locally advanced unresectable non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(9): 1283-1287
Nowara, E.; Suwiński, R.ł 2005: Time factor in radiotherapy and chemotherapy for small cell lung cancer Pneumonologia i Alergologia Polska 73(1): 23-31
Tsujie, M.; Shibata, N.; Nomura, T.; Tanaka, T.; Morimoto, T.; Fujita, S.; Kitani, K.; Nakahira, S.; Okuda, H.; Takeda, M. 2003: A patient with stage IVb small cell carcinoma of the esophagus who survived 23 months after systemic cancer chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 271-275
Wiatr, E.; Bestry, I.; Zych, J.; Grymiński, J. 1993: Stage and regression time of radiological changes in patients treated for small cell lung cancer Pneumonologia i Alergologia Polska 61(1-2): 46-51
Prados, M. 1982: Small cell lung cancer at Earl K. Long Memorial Hospital Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 134(3): 73-78
Satoh, H.; Ishikawa, H.; Ohara, G.; Kagohashi, K.; Kurishima, K.; Ohtsuka, M.; Hizawa, N. 2007: Long-term survivors after chemotherapy in advanced non-small cell lung cancer Anticancer Research 27(6c): 4457-4460
Sahin, C.; Omar, M.; Tunca, H.; Kalemci, S.; Ozseker, B.; Akbaba, G.; Tanriverdi, O. 2015: Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(6): 1576-1584
Mitsudomi, T.; Oyama, T.; Gazdar, A.F.; Minna, J.D.; Okabayashi, K.; Shirakusa, T. 1992: Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance Nihon Geka Gakkai Zasshi 93(9): 944-947
Chen, Y.M.; Tsai, C.M.; Perng, R.P. 1992: Small cell lung cancer and long-term survival: our experience in VGH-Taipei from 1971 to 1985 Zhonghua Yi Xue Za Zhi 49(4): 271-276
Ol'khovskaia, I.G.; Frank, G.A. 1985: All-Union registry data on long-term surviving patients with small cell lung cancer Voprosy Onkologii 31(10): 15-18